You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

alemtuzumab

Showing 51 - 75 of 145
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Kidney Transplant Trial in Chicago (Alemtuzumab)

Terminated
Has Results
  • Kidney Transplant
  • Alemtuzumab
  • Chicago, Illinois
    Northwestern Memorial Hospital
Mar 27, 2019

Sickle Cell Disease Trial in Chicago (procedure, drug, radiation)

Terminated
Has Results
  • Sickle Cell Disease
  • Haploidentical Transplant
  • +4 more
  • Chicago, Illinois
    University of Illinois Cancer Center
Aug 22, 2019

Leukemia, Acute Lymphocytic (ALL), Leukemia, Myeloid, Acute(AML), Leukemia, Myeloid, Chronic(CML) Trial in Memphis (device,

Completed
Has Results
  • Leukemia, Acute Lymphocytic (ALL)
  • +7 more
  • CliniMACS
  • +11 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Apr 3, 2020

Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 Trial in United States

Completed
Has Results
  • Acute Lymphoblastic Leukemia
  • Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
  • Alemtuzumab
  • +20 more
  • Palo Alto, California
  • +100 more
Aug 3, 2022

Multiple Sclerosis Trial (Alemtuzumab)

Completed
Has Results
  • Multiple Sclerosis
  • Alemtuzumab
  • (no location specified)
Nov 13, 2018

Non Hodgkin Lymphoma, High-grade B-cell Lymphoma, Diffuse Large B Cell Lymphoma Trial in Boston (Cyclophosphamide, Alemtuzumab)

Terminated
  • Non Hodgkin Lymphoma
  • +2 more
  • Boston, Massachusetts
  • +1 more
Jan 10, 2019

Kidney Transplantation Trial in United Kingdom (Alemtuzumab, Basiliximab, Sirolimus)

Completed
Has Results
  • Kidney Transplantation
  • Alemtuzumab
  • +3 more
  • Oxford, Oxon, United Kingdom
  • +19 more
Mar 23, 2020

Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in United States (biological, drug, procedure, radiation)

Withdrawn
  • Leukemia
  • +4 more
  • alemtuzumab
  • +6 more
  • La Jolla, California
  • +23 more
Nov 25, 2019

Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid

Completed
Has Results
  • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
  • +99 more
  • alemtuzumab
  • +6 more
  • Denver, Colorado
  • +6 more
Jan 15, 2020

Leukemia, Myeloma, Myeloproliferative Diseases Trial in Houston (drug, procedure, behavioral)

Terminated
Has Results
  • Leukemia
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jun 24, 2019

Adrenoleukodystrophy, Metachromatic Leukodystrophy, Globoid Cell Leukodystrophy Trial in Minneapolis (drug, procedure,

Completed
Has Results
  • Adrenoleukodystrophy
  • +8 more
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Jul 10, 2019

During the Two First Years of Lemtrada Treatment

Unknown status
  • Multiple Sclerosis
  • Alemtuzumab
  • Aarhus, Jutland, Denmark
    Aarhus University, Health, Section for Sport Science
Jan 15, 2019

Graft Rejection Trial in Winston-Salem (Alemtuzumab, Anti-Thymocyte Globulin)

Completed
Has Results
  • Graft Rejection
  • Alemtuzumab
  • Anti-Thymocyte Globulin
  • Winston-Salem, North Carolina
    Wake Forest University Baptist Medical Center
Aug 7, 2018

Leukemia, Lymphoma, Neuroblastoma Trial in New York (Alemtuzumab, Total Body Irradiation, Melphalan)

Terminated
Has Results
  • Leukemia
  • +4 more
  • Alemtuzumab
  • +9 more
  • New York, New York
    Columbia Presbyterian Medical Center
Mar 4, 2019

Leukemia Trial in United States (rituximab, cyclophosphamide, pentostatin)

Completed
Has Results
  • Leukemia
  • rituximab
  • +3 more
  • Scottsdale, Arizona
  • +142 more
Nov 9, 2020

Myelodysplastic Syndrome, Hodgkin's Lymphoma, Non-Hodgkin's Disease Trial run by the NCI (Rituximab, Cyclosporine, Allogenic

Completed
Has Results
  • Myelodysplastic Syndrome
  • +4 more
  • Rituximab
  • +7 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Feb 11, 2019

Chronic Granulomatous Disease Trial in Houston (drug, biological, procedure)

Completed
Has Results
  • Chronic Granulomatous Disease
  • Houston, Texas
    Texas Children's Hospital
Oct 11, 2018

Prolymphocytic Leukemia Trial in Austria, Germany (alemtuzumab, cyclophosphamide, fludarabine phosphate)

Completed
  • Prolymphocytic Leukemia
  • alemtuzumab
  • +3 more
  • Vienna, Austria
  • +18 more
May 9, 2018

B-cell Chronic Lymphocytic Leukemia Trial in Austria (Fludarabine phosphate, Alemtuzumab)

Completed
  • B-cell Chronic Lymphocytic Leukemia
  • Fludarabine phosphate
  • Alemtuzumab
  • Feldkirch, Austria
  • +7 more
Dec 6, 2017

Transplant; Failure, Kidney Trial in Miami (Alemtuzumab, Daclizumab, Thymoglobulin)

Completed
Has Results
  • Transplant; Failure, Kidney
  • Alemtuzumab
  • +2 more
  • Miami, Florida
    University of Miami Miller School of Medicine
Nov 5, 2017

Lymphocytic Leukemia Trial in Scottsdale, Rochester (alemtuzumab, everolimus)

Completed
Has Results
  • Lymphocytic Leukemia
  • Scottsdale, Arizona
  • +1 more
Aug 28, 2017

Histiocytosis, Langerhans-cell Trial in Minneapolis (biological, drug, procedure)

Terminated
Has Results
  • Histiocytosis, Langerhans-cell
  • alemtuzumab
  • +3 more
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Dec 3, 2017

Congenital Amegakaryocytic Thrombocytopenia, Diamond-blackfan Anemia, Leukemia Trial in San Francisco, Madison (biological,

Completed
Has Results
  • Congenital Amegakaryocytic Thrombocytopenia
  • +4 more
  • alemtuzumab
  • +9 more
  • San Francisco, California
  • +1 more
Aug 30, 2017

Alemtuzumab on Blood-brain-barrier and Brain's Metabolism in

Unknown status
  • Multiple Sclerosis
  • Alemtuzumab
  • Glostrup, Copenhagen Capital Region, Denmark
    Functional Imaging Unit, Department of Clinical Physiology, Nucl
Jun 16, 2017

Leukemia Trial in Houston (Alemtuzumab)

Terminated
Has Results
  • Leukemia
  • Alemtuzumab
  • Houston, Texas
    UT MD Anderson Cancer Center
Mar 28, 2017